74 related articles for article (PubMed ID: 18292870)
1. PET (positron emission tomography) imaging of biomolecules using metal-DOTA complexes: a new collaborative challenge by chemists, biologists, and physicians for future diagnostics and exploration of in vivo dynamics.
Tanaka K; Fukase K
Org Biomol Chem; 2008 Mar; 6(5):815-28. PubMed ID: 18292870
[TBL] [Abstract][Full Text] [Related]
2. Gallium-68 PET: a new frontier in receptor cancer imaging.
Al-Nahhas A; Win Z; Szyszko T; Singh A; Nanni C; Fanti S; Rubello D
Anticancer Res; 2007; 27(6B):4087-94. PubMed ID: 18225576
[TBL] [Abstract][Full Text] [Related]
3. In vivo imaging of folate receptor positive tumor xenografts using novel 68Ga-NODAGA-folate conjugates.
Fani M; Tamma ML; Nicolas GP; Lasri E; Medina C; Raynal I; Port M; Weber WA; Maecke HR
Mol Pharm; 2012 May; 9(5):1136-45. PubMed ID: 22497506
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo characterization of 64Cu-labeled Abegrin, a humanized monoclonal antibody against integrin alpha v beta 3.
Cai W; Wu Y; Chen K; Cao Q; Tice DA; Chen X
Cancer Res; 2006 Oct; 66(19):9673-81. PubMed ID: 17018625
[TBL] [Abstract][Full Text] [Related]
5. Matching Chelators to Radiometals for Positron Emission Tomography Imaging- Guided Targeted Drug Delivery.
Deng H; Wang H; Li Z
Curr Drug Targets; 2015; 16(6):610-24. PubMed ID: 26148988
[TBL] [Abstract][Full Text] [Related]
6. PET radiometals for antibody labeling.
Aluicio-Sarduy E; Ellison PA; Barnhart TE; Cai W; Nickles RJ; Engle JW
J Labelled Comp Radiopharm; 2018 Jul; 61(9):636-651. PubMed ID: 29341227
[TBL] [Abstract][Full Text] [Related]
7. Generator-based PET radiopharmaceuticals for molecular imaging of tumours: on the way to THERANOSTICS.
Rösch F; Baum RP
Dalton Trans; 2011 Jun; 40(23):6104-11. PubMed ID: 21445433
[TBL] [Abstract][Full Text] [Related]
8. Optimizing positron emission tomography image acquisition protocols in integrated positron emission tomography/magnetic resonance imaging.
Hartung-Knemeyer V; Beiderwellen KJ; Buchbender C; Kuehl H; Lauenstein TC; Bockisch A; Poeppel TD
Invest Radiol; 2013 May; 48(5):290-4. PubMed ID: 23399811
[TBL] [Abstract][Full Text] [Related]
9. Bio-imaging and cancer targeting with glycoproteins and N-glycans.
Fukase K; Tanaka K
Curr Opin Chem Biol; 2012 Dec; 16(5-6):614-21. PubMed ID: 23176972
[TBL] [Abstract][Full Text] [Related]
10. (64)Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor alpha(v)beta(3) integrin expression.
Li ZB; Cai W; Cao Q; Chen K; Wu Z; He L; Chen X
J Nucl Med; 2007 Jul; 48(7):1162-71. PubMed ID: 17574975
[TBL] [Abstract][Full Text] [Related]
11. In vivo evaluation and small-animal PET/CT of a prostate cancer mouse model using 64Cu bombesin analogs: side-by-side comparison of the CB-TE2A and DOTA chelation systems.
Garrison JC; Rold TL; Sieckman GL; Figueroa SD; Volkert WA; Jurisson SS; Hoffman TJ
J Nucl Med; 2007 Aug; 48(8):1327-37. PubMed ID: 17631556
[TBL] [Abstract][Full Text] [Related]
12. Conjugation of DOTA-like chelating agents to peptides and radiolabeling with trivalent metallic isotopes.
Sosabowski JK; Mather SJ
Nat Protoc; 2006; 1(2):972-6. PubMed ID: 17406332
[TBL] [Abstract][Full Text] [Related]
13. Immuno-PET: a navigator in monoclonal antibody development and applications.
van Dongen GA; Visser GW; Lub-de Hooge MN; de Vries EG; Perk LR
Oncologist; 2007 Dec; 12(12):1379-89. PubMed ID: 18165614
[TBL] [Abstract][Full Text] [Related]
14. Labeling peptides with PET radiometals: Vulcan's forge.
Lucignani G
Eur J Nucl Med Mol Imaging; 2008 Jan; 35(1):209-15. PubMed ID: 18038132
[No Abstract] [Full Text] [Related]
15. Evaluation of feasibility and image quality of 68Ga-DOTATOC positron emission tomography/magnetic resonance in comparison with positron emission tomography/computed tomography in patients with neuroendocrine tumors.
Gaertner FC; Beer AJ; Souvatzoglou M; Eiber M; Fürst S; Ziegler SI; Brohl F; Schwaiger M; Scheidhauer K
Invest Radiol; 2013 May; 48(5):263-72. PubMed ID: 23385399
[TBL] [Abstract][Full Text] [Related]
16. Microfluidic labeling of biomolecules with radiometals for use in nuclear medicine.
Wheeler TD; Zeng D; Desai AV; Önal B; Reichert DE; Kenis PJ
Lab Chip; 2010 Dec; 10(24):3387-96. PubMed ID: 20941431
[TBL] [Abstract][Full Text] [Related]
17.
Drescher R; Greiser J; Gröber S; Weisheit T; Freesmeyer M
J Nucl Med; 2024 May; 65(5):822. PubMed ID: 38485269
[No Abstract] [Full Text] [Related]
18. In vivo evaluation of medical device-associated inflammation using a macrophage-specific positron emission tomography (PET) imaging probe.
Zhou J; Hao G; Weng H; Tsai YT; Baker DW; Sun X; Tang L
Bioorg Med Chem Lett; 2013 Apr; 23(7):2044-7. PubMed ID: 23481649
[TBL] [Abstract][Full Text] [Related]
19. A brief overview of metal complexes as nuclear imaging agents.
MacPherson DS; Fung K; Cook BE; Francesconi LC; Zeglis BM
Dalton Trans; 2019 Oct; 48(39):14547-14565. PubMed ID: 31556418
[TBL] [Abstract][Full Text] [Related]
20. Bimodal MR-PET agent for quantitative pH imaging.
Frullano L; Catana C; Benner T; Sherry AD; Caravan P
Angew Chem Int Ed Engl; 2010 Mar; 49(13):2382-4. PubMed ID: 20191650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
